Skip to main content

Day: December 1, 2024

Calibre Mining Responds to Condor Gold Announcement

VANCOUVER, British Columbia, Dec. 01, 2024 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) reports that it was referenced in a Condor Gold news release. Condor Gold initiated the sale process for their La India gold asset two years ago. During this time, Calibre acknowledges having engaged in discussions with Condor regarding the potential acquisition of the La India gold asset, which aligns well within Calibre’s Hub & Spoke operation. However, Calibre confirms that it is not currently in discussions with Condor, nor does it have an active offer. At this time, unless Condor is willing to reengage in meaningful discussions, Calibre does not envision completing an acquisition. About Calibre Calibre (TSX: CXB) is a Canadian-listed, Americas focused, growing...

Continue reading

Itron’s Low Voltage Distributed Energy Resource Management System to Manage Rooftop Solar Generation in Australia

Data-Driven Solution to Enable Jemena, at AEMO’s Direction, to Remotely Manage Consumer Energy Resources for Energy System Reliability LIBERTY LAKE, Wash., Dec. 01, 2024 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is collaborating with Jemena, a provider of gas and electricity services to millions of customers in Australia, to deploy Itron’s Low Voltage Distributed Energy Resource Management System (LV DERMS) to manage rooftop solar generation and enhance resiliency within the energy system. The innovative data-driven and flexible solution transforms the planning and operating risks caused by consumer energy resources (CERs), specifically solar, into opportunities. LV DERMS will help address challenges stemming from the integration of CER into...

Continue reading

Board Accepts Carlos Tavares’ Resignation as Chief Executive Officer

Board Accepts Carlos Tavares’ Resignation as Chief Executive OfficerCreation of Interim Executive Committee to be chaired by John Elkann New CEO will be appointed in the first half of 2025 Full year 2024 financial guidance confirmedAMSTERDAM, December 1, 2024 – Stellantis N.V. (“Stellantis” or “the Company”) announces that the Company’s Board of Directors, under the Chairmanship of John Elkann, accepted Carlos Tavares’ resignation today from his role as Chief Executive Officer with immediate effect. The process to appoint the new permanent Chief Executive Officer is well under way, managed by a Special Committee of the Board, and will be concluded within the first half of 2025. Until then, a new Interim Executive Committee, chaired by John Elkann, will be established. Stellantis confirms the guidance it presented to the financial...

Continue reading

Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

Siemens Healthineers and DeepHealth have signed a letter of intent to create AI-powered SmartTechnology™ to improve patient experience and operational efficiency in ultrasound. The collaboration aims to facilitate remote operations, collaboration, and enhanced interpretation capabilities for increased diagnostic accuracy and consistency by combining Siemens Healthineers’ Acuson Sequoia with RadNet’s DeepHealth SmartSonography™. A live demonstration of the technology will be held Tuesday, December 3, 10:00 AM – 10:30 AM CT at Booth #2529, South Hall, Level 3 at RSNA 2024, Chicago, IL.LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) — Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today announced...

Continue reading

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – Conference call on Saturday, Dec. 7 at 9:00 a.m. ET to discuss full data set UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 01, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of an abstract regarding petosemtamab, a Biclonics® targeting EGFR and LGR5, in previously treated (2L+) patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (r/m HNSCC) on the European Society for Medical Oncology (ESMO®) Asia Congress website. The abstract presents updated clinical data on petosemtamab from the...

Continue reading

Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024

Philips CT 5300 with AI-enabled workflowClinical image of the heart with Precise Cardiac on Philips CT 5300December 1, 2024Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and interventional imaging accessible to more patients, including reading support with Automated AI-enabled Philips Advanced Visualization Workspace applications Philips collaborates with Annalise.ai to evaluate streamlining workflows to prioritize time-sensitive casesAmsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a boost in confidence in clinical decision-support with AI and smart workflow automation capabilities in the company’s recently introduced CT 5300 system, which is making...

Continue reading

Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24

philips-next-gen-blueseal-mri-2ct-5300-product-image-2next-gen-blueseal-mri-with-smart-readingDecember 1, 2024 Philips’ intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely position the company to drive precision imaging for a greater number of patients Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled the company’s latest AI-powered diagnostic and treatment imaging innovations to advance precise imaging with faster, easier and more efficient workflows. Addressing key challenges faced by radiologists, these innovations are complemented by Philips’ industry-leading expertise in cloud-based data management, advanced visualization, automation, and AI....

Continue reading

GPM Investments, LLC Launches Holiday Retail Campaign for the Muscular Dystrophy Association (MDA) in 27 States

RICHMOND, Va., Dec. 01, 2024 (GLOBE NEWSWIRE) — Today GPM Investments, LLC launched the MDA Holiday Retail Campaign in support of Muscular Dystrophy Association’s (MDA) mission at approximately 1,500 locations across the United States from December 1 through December 31, 2024. For more than 13 years GPM Investments has raised funds to accelerate research, advance care, and advocate to empower families living with muscular dystrophy, ALS, and related neuromuscular diseases. We invite customers to participate in the MDA Holiday retail campaign by purchasing a $1 or $5 pinup or rounding up their purchase. Donations made by customers will be displayed on special MDA Holiday pinups in each location, showing support for MDA families. Donations to this year’s holiday campaign may also be made directly online here.  Today GPM Investments,...

Continue reading

RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai’s Platform to Develop a New AI Control System for Clinical AI Performance and Safety

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance monitoring, and safety, with the aim to accelerate the adoption of AI. DeepHealth currently monitors the performance of DeepHealth’s SmartMammo™ AI-powered solution for breast cancer detection at RadNet. Through the collaboration, the two companies aim to expand, productize and scale this control system across more applications to other customers.Furthermore, DeepHealth will embed CARPL.ai’s cutting-edge AI orchestration capabilities that enable easy selection, implementation, and monitoring of appropriate AI models within DeepHealth’s cloud-native operating system, DeepHealth OS.LOS ANGELES and SOMERVILLE, Mass., Dec. 01, 2024 (GLOBE...

Continue reading

NIO Inc. Provides November 2024 Delivery Update

20,575 vehicles were delivered in November 2024, increasing by 28.9% year-over-year 190,832 vehicles were delivered year-to-date in 2024, increasing by 34.4% year-over-year Cumulative deliveries reached 640,426 as of November 30, 2024  SHANGHAI, Dec. 01, 2024 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its November 2024 delivery results. The Company delivered 20,575 vehicles in November 2024, representing an increase of 28.9% year-over-year. The deliveries consisted of 15,493 vehicles from the Company’s premium smart electric vehicle brand NIO, and 5,082 vehicles from the Company’s family-oriented smart electric vehicle brand ONVO. Cumulative deliveries reached 640,426 as of November 30, 2024. November...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.